Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4B |
| 2 |
TC Energy
TRP
|
+$1.99B |
| 3 |
Amazon
AMZN
|
+$1.97B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.83B |
| 5 |
NVIDIA
NVDA
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.57B |
| 2 |
Scotiabank
BNS
|
+$1.51B |
| 3 |
Enbridge
ENB
|
+$1.47B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.02B |
| 5 |
Medtronic
MDT
|
+$871M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 9.2% |
| 3 | Consumer Discretionary | 8.28% |
| 4 | Communication Services | 6.4% |
| 5 | Healthcare | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6126
Spruce Power Holding Corp
SPRU
$43.2M
| $32.1K | ﹤0.01% |
13,109
-9,181
| -41% | -$14.3K |
|
6127
INmune Bio
INMB
$50.8M
| $31.7K | ﹤0.01% |
15,304
-8,294
| -35% | -$19K |
|
6128
Torrid Holdings
CURV
$264M
| $31.6K | ﹤0.01% |
18,051
-30,006
| -62% | -$69K |
|
6129
Telomir Pharmaceuticals
TELO
$79.1M
| $31.5K | ﹤0.01% |
22,636
-137,958
| -86% | -$208K |
|
|
RNWWW
6130
ReNew Energy Global PLC Warrant
RNWWW
$57.4K
| $31.3K | ﹤0.01% |
686,199
| – | – |
|
6131
Verde Clean Fuels
VGAS
$29.8M
| $31.1K | ﹤0.01% |
+10,213
| New | +$31.1K |
|
6132
SELLAS Life Sciences
SLS
$2.32B
| $31K | ﹤0.01% |
19,265
-446,241
| -96% | -$795K |
|
6133
Century Therapeutics
IPSC
$363M
| $30.2K | ﹤0.01% |
60,682
-215,296
| -78% | -$116K |
|
|
IPM
6134
Intelligent Protection Management Corp
IPM
$23.7M
| $30.2K | ﹤0.01% |
15,184
-18,566
| -55% | -$36.9K |
|
|
PBK
6135
PowerBank Corp
PBK
$28.6M
| $29.2K | ﹤0.01% |
+19,057
| New | +$32K |
|
|
MSPR
6136
DELISTED
MSP Recovery Inc
MSPR
| $29K | ﹤0.01% |
+25,621
| New | +$113K |
|
|
ICG
6137
Intchains Group
ICG
$51.6M
| $28K | ﹤0.01% |
+16,531
| New | +$37.4K |
|
6138
CBAK Energy Technology Ltd
CBAT
$44.1M
| $27.7K | ﹤0.01% |
30,957
-41,606
| -57% | -$40.6K |
|
|
ZOOZ
6139
ZOOZ Strategy Ltd
ZOOZ
$42.5M
| $27.6K | ﹤0.01% |
+644
| New | +$23.8K |
|
6140
IGC Pharma
IGC
$25.9M
| $27.3K | ﹤0.01% |
65,541
| – | – |
|
|
ZENV
6141
DELISTED
Zenvia
ZENV
| $25.2K | ﹤0.01% |
18,834
-10,651
| -36% | -$15.8K |
|
6142
Oxford Square Capital
OXSQ
$158M
| $24.3K | ﹤0.01% |
+15,298
| New | +$33.6K |
|
|
IOBT
6143
DELISTED
IO Biotech
IOBT
| $24.2K | ﹤0.01% |
+66,564
| New | +$115K |
|
6144
Alpha Tau Medical Warrant
DRTSW
$77.3M
| $23.9K | ﹤0.01% |
69,409
| – | – |
|
6145
SAB Biotherapeutics
SABS
$294M
| $22.6K | ﹤0.01% |
+11,221
| New | +$25.4K |
|
6146
Rafael Holdings
RFL
$97.2M
| $21.6K | ﹤0.01% |
+15,901
| New | +$26.7K |
|
|
SHMDW
6147
SCHMID Group N.V. Warrants
SHMDW
| $20.5K | ﹤0.01% |
75,239
| – | – |
|
|
LNAI
6148
Lunai Bioworks
LNAI
$11.6M
| $20.5K | ﹤0.01% |
1,803
-5,634
| -76% | -$109K |
|
6149
KLX Energy Services
KLXE
$43.3M
| $19.7K | ﹤0.01% |
+10,277
| New | +$19.2K |
|
|
CLSKW
6150
CleanSpark Inc Warrant
CLSKW
$282K
| $19K | ﹤0.01% |
39,595
| – | – |
|
Similar funds
Goldman Sachs's Q3 2025 Portfolio in Review
As of Q3 2025, Goldman Sachs held 6,765 positions worth $817B, up 11% from $736B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q3 2025 filing shows 707 new, 2,950 increased, 2,106 reduced and 470 closed positions. Its largest new stake was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M. The largest sale was iShares Russell 2000 ETF, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q3 2025 buy was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M.
- Goldman Sachs added most to Microsoft in Q3 2025, an estimated $4B increase.
- Goldman Sachs's biggest Q3 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $1.57B.
- Goldman Sachs fully exited Ansys in Q3 2025, selling an estimated $564M.
- Goldman Sachs's ten largest holdings make up 22% of its $817B portfolio in Q3 2025.
- Goldman Sachs opened 707 new positions and closed 470 in Q3 2025.
- Goldman Sachs's portfolio value rose 11% quarter-over-quarter to $817B.
Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.